This wiki has undergone a migration to Confluence found Here
20171027 PLA call
Jump to navigation
Jump to search
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes |
Date: 2017-10-27 Time: 11:30 AM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| x | Calvin Beebe | ||
| x | Lorraine Constable | ||
| Jean Duteau, | |||
| Tony Julian | |||
| Paul Knapp | |||
| x | Austin Kreisler, | ||
| x | Mary Kay McDaniel | ||
| Brian Pech | |||
| Wayne Kubick | |||
| x | John Roberts | ||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20171013_PLA_call review
- Status updates for CDAMG and CIMI MG
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
Agenda review
- Notes of 20171013_PLA_call review
- Mary Kay got list of products and published artifacts for CDA from Dave/Lynn. Sent out to group.
- CDAMG
- ACTION: Anne add TSC agenda item for TSC endorsing Structured Documents being lead methodology group for CDA product family.
- Austin notes that working on templates for C-CDA will have to start being farmed out to other groups.
- ACTION: Anne add TSC agenda item for TSC endorsing Structured Documents being lead methodology group for CDA product family.
- CIMI-MG
- Lorraine: They have been working through getting things under one umbrella; met with Publishing WG to work on web-based publishing.
- They have been talking about detailed clinical models. They are anxious to get them out and usable, but the reference model changes are coming in and will create large changes preventing going to ballot. Want to get them out, published, and reviewed in a less formal form than the full ballot, then into the ballot on a different cycle - so a non-ballot review process. As we get CIMI-MG stood up, it's another thing to sort out.
- ACTION: Add discussion topic for SGB: Product families develop an approach to indicating the maturity of the products
- For next time: Candidate selection for CIMI and V2 mgmgt group
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved
